Edition:
United Kingdom

BB Biotech AG (BION.S)

BION.S on Swiss Exchange

69.15CHF
4:29pm GMT
Change (% chg)

CHF-1.15 (-1.64%)
Prev Close
CHF70.30
Open
CHF69.90
Day's High
CHF69.90
Day's Low
CHF68.40
Volume
69,392
Avg. Vol
121,765
52-wk High
CHF74.00
52-wk Low
CHF53.05

Chart for

About

BB Biotech AG is a Switzerland-based investment company, which principal activity is to invest in companies active in the biotechnology industry. BB Biotech AG invests mainly in companies operating in such sectors as oncology, infectious diseases, cardiovascular diseases, metabolic diseases and autoimmune diseases. The Company’s... (more)

Overall

Beta: 1.16
Market Cap(Mil.): CHF3,731.19
Shares Outstanding(Mil.): 55.40
Dividend: 2.75
Yield (%): 4.08

Financials

  Industry Sector
P/E (TTM): -- 83.93 16.60
EPS (TTM): -- -- --
ROI: -- 1.66 10.66
ROE: -- 2.58 14.30

BRIEF-BB Biotech FY Net Result Turns to Profit Of CHF 688 Million

* FY NET GAIN OF CHF 688 MN COMPARED TO A NET LOSS OF CHF 802 MN IN PREVIOUS PERIOD

16 Feb 2018

BRIEF-BB Biotech to propose 3.30 Sfr dividend for 2017

* SHOWS A DOUBLE-DIGIT TOTAL RETURN FOR 2017 - MID CAPS OVERDELIVER ON INNOVATION AND ARE BECOMING A KEY UPSIDE TRIGGER

19 Jan 2018

BRIEF-BB Biotech Reports 5.6% Passive Stake In Voyager Therapeutics

* BB BIOTECH AG REPORTS 5.6% PASSIVE STAKE IN VOYAGER THERAPEUTICS AS OF JAN 3 - SEC FILING‍​ Source text: (http://bit.ly/2CZEeZD) Further company coverage:

10 Jan 2018

BRIEF-BB Biotech Q3 net profit down at CHF 365 million

* PRODUCT APPROVALS AND SOLID COMPANY RESULTS LEAD THE BIOTECH SECTOR HIGHER

20 Oct 2017

Earnings vs. Estimates